Jamjoom Pharmaceuticals Factory Co. Announces the Results of the Extraordinary General Assembly Meeting, ( First Meeting )
| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Jamjoom Pharmaceuticals Factory Company (the “Company”) is pleased to announce the results of the Extraordinary General (First Meeting) Assembly held on Tuesday 2/09/1445H corresponding to 12/03/2024G after the quorum for the validity of the meeting was completed. |
| City and Location of the General Assembly's Meeting | Company’s headquarters in Jeddah, via modern technology means. |
| Date of the General Assembly's Meeting | 2024-03-12 Corresponding to 1445-09-02 |
| Time of the General Assembly’s Meeting | 22:00 |
| Percentage of Attending Shareholders | 77.31% |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | The meeting was attended by the following Board Members:
1- Mr. Mahmoud Yousuf Jamjoom (Chairman) 2- Mr. Ahmed Yousuf Jamjoom (Vice Chairman) 3- Mr. Mohammed Yousuf Jamjoom (Member) 4- Mrs. Alaa Yousuf Jamjoom( Member) 5- Mr.Georges P. Schorderet (Member)
The following were unable to attend this meeting:
1- Mr. Yousuf Mohammed Salah Jamjoom (Member) 2- Mr. Faris Ibrahim Abdullah Al Ghannam (Member) 3- Mr.Noor Ahmed Kather Pasha Sheriff (Member) 4- Mr. Michel Marcel Jean-Marie Le Bars (Member) |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | The following committee chairpersons attended the meeting:
Mr. Georges P. Schorderet (Chairman of the Nomination and Remuneration Committee and Chairman of the Executive Committee). |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | Please Check the attached document |
| Additional Information | The Board of Directors of Jamjoom Pharmaceuticals Factory Company would like to thank the respected shareholders for their participation and attendance of the Extraordinary General Assembly Meeting (First Meeting).
For any inquiries, please directly contact the Investor Relations Department through:
Email: |
| Attached Documents |  |
Comments